• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarUSA Market OverviewCanada Market OverviewEurope Market Overview
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Swing Trading Course
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of IMNP

Immune Pharmaceuticals Inc. (IMNP) Stock News

USA - NASDAQ:IMNP -

0.064
-0.1 (-61.21%)
Last: 9/10/2018, 5:44:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

IMNP Latest News, Press Relases and Analysis

All
Press Releases
8 years ago - By: Active-Investors - Mentions: JNJ
News Image

Wired News – Johnson & Johnson to Pay Compensatory Damages over Claims Linking Cancer to Asbestos in Talc

8 years ago - By: dailystocktracker.com - Mentions: ZGNX SHPG ABBV
News Image

Technical Snapshots for These Drug Makers Stocks -- Immune Pharma, Zogenix, Shire, and AbbVie

7 years ago - By: Benzinga - Mentions: ABMD ALKS ALXN AMGN ...
News Image

Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold

7 years ago - By: Benzinga - Mentions: AGEN CLDX IBB OPNT ...
News Image

Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap

8 years ago - By: Analyst Ratings
News Image

Maxim Group Thinks Immune Pharmaceuticals’ Stock is Going to Recover

8 years ago - By: Immune Pharmaceuticals Inc.
News Image

Immune Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides a Corporate Update

8 years ago - By: Immune Pharmaceuticals Inc.
News Image

Immune Pharmaceuticals Inc. Announces Closing of $18,000,000 Public Offering of Convertible Preferred Stock and Warrants